On Friday morning, we sold four stocks: AAR Corporation (NYSE: AIR), ChannelAdvisor (NYSE: ECOM), AngioDynamics (NASDAQ: ANGO) and Sotheby’s (NYSE: BID). All four stocks have exceeded our suggested buy-up-to price. Amidst the higher market volatility, we decided to take the gains. AAR Corp. has been a consistent performer for us… Read More
Scott Chan moved from China to the U.S. with family at the age of ten. He passed the rigorous entrance exam and attended the merit-based Stuyvesant High School, widely held to be best public school in New York City. He earned undergraduate degrees from New York University followed by an MBA degree from the Zicklin School of Business at Baruch College.
Shortly thereafter Scott partnered with Dr. Stephen Leeb on numerous financial publications. Today, he serves as the lead analyst for Real World Investing and The Complete Investor.
Mr. Chan is an avid baseball fan and enjoys outdoor activities in his spare time. A multicultural person, he reads Chinese and speaks fluent Mandarin and Cantonese Chinese.
Analyst Articles
Sell AAR Corporation (NYSE: AIR), AngioDynamics (NASDAQ: ANGO). ChannelAdvisor (NYSE: ECOM) and Sotheby’s (NYSE: BID). We recommend taking gains on AIR, ANGO, ECOM, and BID. More details to come in today’s weekly update later. Read More
Writing options can be a low-risk way to generate extra income and boost a portfolio's return. However, investors should be careful not to go overboard and write too many options at once. Read More
Even with the decline on Friday, the S&P 500 finished the week in the green and recovered last week’s lost ground as trade-war fears moderated. Xi Jinping, China’s paramount leader, gave a speech about lowering tariffs on auto imports and tightening regulations surrounding intellectual property as part of an effort… Read More
Utility stocks may not be the most exciting investments out there, but they are dependable income-generating vehicles for conservative investors. And when market conditions deteriorate, they provide a haven. Read More
AngioDynamics (NASDAQ: ANGO), which we covered last week, received an upgrade from Raymond James, an analytic firm, this week. The stock soared to $19 at one point, its highest mark since 2015. It now trades at our suggested buy-up-to price of $18 and has gained about 9% this week. Read More
AngioDynamics (NASDAQ: ANGO) reported quarterly earnings on Thursday morning. In the third fiscal 2018 quarter (ended February 2018), the company had revenue of $83.9 million, slightly below expectations. On the plus side, gross margin improved 3 percentage points, and earnings (adjusted for unusual items) was $0.25 per share, above expectations. Read More
Using four key traits to find little-known stocks that could deliver significantly market-beating returns over time, we unearthed a stock flying under the radar that fits all the criteria. Read More
Yesterday, the S&P 500 dropped 2.5%, its worst day in six weeks. President Trump’s new announcement of about $50 billion in tariffs targeting Chinese imports has sparked new trade-war concerns. The U.S. will also restrict Chinese investment in the U.S. In response, China’s Ministry of Commerce… Read More
Sell TAL Education (NYSE: TAL). Last week, we mentioned that we moved TAL Education to our watch list as a possible sell candidate due to an action taken by China’s Ministry of Education. Based on the uncertainties created by President Trump’s focus of tariffs on China and the possible deterioration… Read More